胎儿和新生儿同种免疫性血小板减少症:无证据表明全身性炎症可调节疾病严重程度。胎盘炎症可能是关键?
本研究检测了50例抗HPA-1a抗体所致胎儿/新生儿同种免疫性血小板减少症(FNAIT)新生儿和50例无母体HPA抗体检出的血小板减少新生儿的血清炎症标志物。两组C反应蛋白、可溶性CD14、降钙素原和sFlt-1浓度无差异;降钙素原与血小板计数在两队列均呈负相关,sFlt-1仅与FNAIT病例血小板计数相关。未发现全身性炎症是FNAIT血小板减少的相关因素。
要点
- FNAIT组与无HPA抗体血小板减少组炎症标志物浓度无差异。
- 降钙素原与血小板计数在两队列均呈负相关。
- sFlt-1仅与FNAIT病例的血小板计数相关。
核心结论
- 未能确定全身性炎症是FNAIT中血小板减少的相关因素。
- 胎盘释放的抗血管生成酶sFlt-1在FNAIT病例中与血小板计数相关。
- 作者提出假说:调节FNAIT疾病严重程度的可能是胎盘炎症而非全身性炎症。
研究设计与样本
- 检测血小板减少新生儿血清样本中一组稳定的炎症标志物。
- n=50例因抗HPA-1a抗体诊断为FNAIT,n=50例为无母体HPA抗体检出的血小板减少。
主要发现
- C反应蛋白、可溶性CD14、降钙素原和sFlt-1浓度在两组间无差异。
- C反应蛋白或可溶性CD14与血小板计数无相关性。
- 降钙素原浓度与新生儿血小板计数在两队列均呈负相关。
- sFlt-1浓度与血小板计数仅在FNAIT病例中相关。
- 有和无颅内出血的病例间炎症标志物均无统计学差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In fetal/neonatal alloimmune thrombocytopenia (FNAIT), maternal alloantibodies against paternal human platelet antigens (HPA) cross the placenta and lead to platelet destruction. The extent of thrombocytopenia varies among neonates, and inflammation may constitute an important trigger. A set of stable inflammatory markers was measured in serum samples from neonates with low platelet counts, of which n = 50 were diagnosed with FNAIT due to anti-HPA-1a antibodies and n = 50 were thrombocytopenic without detectable maternal HPA antibodies. Concentrations of C-reactive protein, soluble CD14, procalcitonin, and sFlt-1 did not differ between the two cohorts. There was no correlation between C-reactive protein or soluble CD14 and the platelet count, but a negative correlation between procalcitonin concentrations and the neonatal platelet count in both cohorts. sFlt-1 concentration and the platelet count were correlated in FNAIT cases exclusively. None of the inflammatory markers was statistically different between cases with and without intracranial haemorrhage. We were unable to identify systemic inflammation as a relevant factor for thrombocytopenia in FNAIT. The antiangiogenic enzyme sFlt-1, released by the placenta, did correlate with the platelet count in FNAIT cases. Our findings may give rise to the hypothesis that placental inflammation rather than systemic inflammation modulates disease severity in FNAIT.
引用
- Böhm D, Wienzek-Lischka S, Cooper N, et al. Fetal and neonatal alloimmune thrombocytopenia: No evidence of systemic inflammation as a modulator of disease severity. Could placental inflammation be key? Br J Haematol. 2023. PMID: 37571926. doi:10.1111/bjh.19009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。